Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment

<p>Abstract</p> <p>Background</p> <p>The effects of pan-peroxisome proliferator-activated receptor (PPAR) ligand bezafibrate on N-terminal pro-B type natriuretic peptide (ProBNP) level in patients with coronary artery disease (CAD) is unknown. The current study aimed to investigate the long-term eff...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Matas Zipora, Schwammenthal Ehud, Adler Yehuda, Fisman Enrique Z, Goldberg Ilan, Boyko Valentin, Inoue Teruo, Node Koichi, Behar Solomon, Tenenbaum Alexander
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2009-01-01
Seri Bilgileri:	Cardiovascular Diabetology
Online Erişim:	http://www.cardiab.com/content/8/1/5
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!